References
- R Jardi, F Rodriguez, M Buti, X Costa, M Cotrina, R Galimany, Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404–10.
- J Amin, MG Law, M Bartlett, JM Kaldor, GJ Dore. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006;368:938–45.
- G Raimondo, C Saitta. Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist. J Hepatol 2008;49:677–9.
- G Raimondo, MR Brunetto, P Pontisso, A Smedile, AM Maina, C Saitta, Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 2006;43:100–7.
- European Association For The Study of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227–42.
- M Cornberg, U Protzer, MM Dollinger, J Petersen, H Wedemeyer, T Berg, Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. Z Gastroenterol 2007;45:1281–328.
- A Potthoff, H Wedemeyer, WO Boecher, T Berg, S Zeuzem, J Arnold, The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 2008;49:688–94.
- CJ Liu, WL Chuang, CM Lee, ML Yu, SN Lu, SS Wu, Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009;136:496–504 e3.